BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 312203)

  • 21. Fine specificity and antigen receptor expression among influenza virus-specific cytolytic T lymphocyte clones.
    Braciale TJ; Henkel TJ; Lukacher A; Braciale VL
    J Immunol; 1986 Aug; 137(3):995-1002. PubMed ID: 2424996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of influenza B virus hemagglutinin containing multibasic residue cleavage sites.
    Brassard DL; Lamb RA
    Virology; 1997 Sep; 236(2):234-48. PubMed ID: 9325231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Murine cell lines stably expressing the influenza virus hemagglutinin gene introduced by a recombinant retrovirus vector are constitutive targets for MHC class I- and class II-restricted T lymphocytes.
    Eager KB; Hackett CJ; Gerhard WU; Bennink J; Eisenlohr LC; Yewdell J; Ricciardi RP
    J Immunol; 1989 Oct; 143(7):2328-35. PubMed ID: 2789261
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-reacting antigens on L5178Y cells which serve as targets for cytotoxic T-lymphocyte lysis during establishment of the tumor dormant state.
    Weinhold KJ; Wheelock EF
    Cancer Res; 1982 Sep; 42(9):3607-16. PubMed ID: 6179603
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence.
    Townsend AR; Bastin J; Gould K; Brownlee GG
    Nature; 1986 Dec 11-17; 324(6097):575-7. PubMed ID: 3491325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recognition of influenza virus hemagglutinin by subtype-specific and cross-reactive proliferative T cells: contribution of HA1 and HA2 polypeptide chains.
    Katz JM; Laver WG; White DO; Anders EM
    J Immunol; 1985 Jan; 134(1):616-22. PubMed ID: 3871116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Purified glycoproteins of influenza virus stimulate cell-mediated cytotoxicity in vivo.
    Arora DJ; Houde M
    Nat Immun Cell Growth Regul; 1988; 7(5-6):287-96. PubMed ID: 3221907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia.
    Nelson DL; Biddison WE; Shaw S
    J Immunol; 1983 Jun; 130(6):2629-34. PubMed ID: 6189897
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fluorescent antigen-transfected target cell cytotoxic T lymphocyte assay for ex vivo detection of antigen-specific cell-mediated cytotoxicity.
    van Baalen CA; Kwa D; Verschuren EJ; Reedijk ML; Boon AC; de Mutsert G; Rimmelzwaan GF; Osterhaus AD; Gruters RA
    J Infect Dis; 2005 Oct; 192(7):1183-90. PubMed ID: 16136460
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hybrid antibody-mediated lysis of virus-infected cells.
    Staerz UD; Yewdell JW; Bevan MJ
    Eur J Immunol; 1987 Apr; 17(4):571-4. PubMed ID: 3494618
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies to hemagglutinin and to H-2 inhibit the cross-reactive cytotoxic T cell populations induced by influenza.
    Askonas BA; Webster RG
    Eur J Immunol; 1980 Feb; 10(2):151-56. PubMed ID: 6966222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acid-induced conformational modification of the hemagglutinin molecule alters interaction of influenza virus with antigen-presenting cells.
    Eisenlohr LC; Gerhard W; Hackett CJ
    J Immunol; 1988 Sep; 141(6):1870-6. PubMed ID: 2459193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.
    Epstein SL; Misplon JA; Lawson CM; Subbarao EK; Connors M; Murphy BR
    J Immunol; 1993 Jun; 150(12):5484-93. PubMed ID: 8390536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lysis of target cells infected with vesicular stomatitis virus (VSV) in the presence of tunicamycin by anti-VSV cytotoxic T lymphocytes.
    Harris DT; Hale AH; Lefrancois L
    J Immunol; 1981 May; 126(5):1914-8. PubMed ID: 6260860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes.
    Koszinowski UH; Allen H; Gething MJ; Waterfield MD; Klenk HD
    J Exp Med; 1980 Apr; 151(4):945-58. PubMed ID: 6154763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells.
    Braciale TJ
    J Exp Med; 1977 Sep; 146(3):673-89. PubMed ID: 302303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell.
    McMichael AJ; Askonas BA
    Eur J Immunol; 1978 Oct; 8(10):705-11. PubMed ID: 309394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of fusion activity of ultraviolet light-inactivated Sendai virus in formation of target antigens recognized by cytotoxic T cells.
    Sugamura K; Shimizu K; Bach FH
    J Exp Med; 1978 Jul; 148(1):276-87. PubMed ID: 78960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytotoxic T cell lysis of target cells fused with liposomes containing influenza virus haemagglutinin and neuraminidase.
    Stitz L; Huang RT; Hengartner H; Rott R; Zinkernagel RM
    J Gen Virol; 1985 Jun; 66 ( Pt 6)():1333-9. PubMed ID: 3874262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influenza virus hemagglutinin-specific cytotoxic T cell response induced by polypeptide produced in Escherichia coli.
    Yamada A; Ziese MR; Young JF; Yamada YK; Ennis FA
    J Exp Med; 1985 Aug; 162(2):663-74. PubMed ID: 3160807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.